Solventum Corporation vs ResMed Inc.
A head-to-head of Solventum Corporation (SOLV) and ResMed Inc. (RMD) across valuation, profitability, growth, and dividends. Green marks the more favourable value on that metric only — not a recommendation.
| Metric | SOLV | RMD |
|---|---|---|
| Market Cap | $13.57B | $27.05B |
| P/E (TTM) | 9.53 | 17.89 |
| Forward P/E | 10.42 | 16.86 |
| P/S | 1.54 | 5.39 |
| P/B | 2.73 | 4.16 |
| EV/EBITDA | 15.51 | 13.65 |
| Dividend Yield | — | 1.26% |
| Profit Margin | 17.33% | 27.44% |
| Gross Margin | 53.47% | 59.36% |
| Operating Margin | 7.59% | 32.79% |
| Revenue Growth (YoY) | -3.09% | +10.81% |
| FCF Yield | -1.60% | 5.81% |
| Debt / Equity | 102.21 | 10.23 |
| Current Ratio | 1.07 | 3.01 |
Share:
Compare Solventum Corporation with others
This comparison is for informational and educational purposes only, based on available data — not a recommendation to buy or sell any stock.